Manufacturing

Challenges and Opportunities for Personalized mRNA Cancer Vaccines
Tech & Innovation Challenges and Opportunities for Personalized mRNA Cancer Vaccines

The current pharmaceutical landscape is witnessing a profound transformation as the successful clinical implementation of personalized mRNA cancer vaccines begins to redefine the standard of care in oncology. This seismic shift is driven by a long-held vision: the ability to train a patient’s own

How Can We Close the Gap in Early Drug Discovery?
Research & Development How Can We Close the Gap in Early Drug Discovery?

The ability of a compound to cross cell membranes and reach intracellular targets is a critical variable that simple test-tube assays cannot measure. This fundamental reality underscores the massive disconnect currently plaguing the pharmaceutical industry, where high-potency molecules identified

CordenPharma Expands Sterile Injectable Capacity in Italy
Management & Regulatory CordenPharma Expands Sterile Injectable Capacity in Italy

CordenPharma is proactively responding to the evolving healthcare landscape by enhancing its capabilities in assembling auto-injectors and other complex drug delivery formats for chronic disease management. As the global pharmaceutical market shifts towards self-administered therapies, the demand

How Can Digital Twins Enhance Bioprocessing Controls?
Biotech & Bioprocessing How Can Digital Twins Enhance Bioprocessing Controls?

Effective digital twin architecture requires a robust data layer that synchronizes information from SCADA systems and laboratory information management systems. In the current landscape of 2026, the biopharmaceutical industry has moved decisively beyond traditional static modeling toward dynamic,

Pharma Industry Adapts to Climate Risks for Business Resilience
Management & Regulatory Pharma Industry Adapts to Climate Risks for Business Resilience

The intricate supply chains required to produce life-saving medications now face unprecedented risks from extreme weather events and critical resource scarcity. The global pharmaceutical sector is currently undergoing a fundamental transformation as climate change shifts from a corporate social

Can 40°C Optimize Growth for Avian Cultivated Protein?
Biotech & Bioprocessing Can 40°C Optimize Growth for Avian Cultivated Protein?

While 37 degrees Celsius is the global default for biological research, it may actually induce a state of chronic metabolic sluggishness in chicken muscle cells. The emergence of cellular agriculture marks a pivotal shift in how the world approaches food security and sustainable protein, yet the

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later